Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial.

Ming Wang,Can Cui,Shi-Ao Yu, Ling-Ling Liang,Jing-Xue Ma,Ai-Cun Fu

Frontiers in pediatrics（2023）

引用 0|浏览4

暂无评分

摘要

After 2 years, 0.02% and 0.01% atropine had no clinical effects on corneal and lens power, ocular and corneal astigmatism, ACD or IOP compared to the control group. 0.02% and 0.01% atropine helped to control myopia progression mainly by reducing AL elongation.

查看译文

关键词

children,efficacy,low-concentration atropine,myopia,ocular biometrics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要